Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia. - Wikidata - awgldk - TriplyDB

Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia.

Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia.

http://www.wikidata.org/entity/Q34235221

about

Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans.Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.Natural killer T cells in atherosclerosis.Natural killer T cells in adipose tissue are activated in lean mice IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells.NKT Cell Hyporesponsiveness Leads to Unrestrained Accumulation of Marginal Zone B Cells in Hypercholesterolemic Apolipoprotein E-Deficient Mice.Natural killer T cells in lipoprotein metabolism and atherosclerosis.

P2860

Q35850754-178D1A6C-91B9-4E0A-9CDD-EC435D872DDB Q37822744-7B9E782D-5C6A-4BB9-9677-8D8B9C1F7B78 Q39105646-31CFBD9F-FFE2-468A-A020-57FB3A87F2F3 Q42845618-E31BD9F9-5198-4686-89BA-01EBA667F9F5 Q47350839-225E9595-C73E-4439-A41C-AD99EB60B59A Q48261376-0F41EABB-4878-492B-A1B1-3D848087E547 Q50190286-59D00370-2F9F-4525-A197-B9A2E74212F7

P2860

Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia.

http://www.wikidata.org/entity/Q34235221

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Development of spontaneous ane ...... a mouse model of dyslipidemia.

@ast

Development of spontaneous ane ...... a mouse model of dyslipidemia.

@en

Development of spontaneous ane ...... a mouse model of dyslipidemia.

@nl

type

label

Development of spontaneous ane ...... a mouse model of dyslipidemia.

@ast

Development of spontaneous ane ...... a mouse model of dyslipidemia.

@en

Development of spontaneous ane ...... a mouse model of dyslipidemia.

@nl

prefLabel

Development of spontaneous ane ...... a mouse model of dyslipidemia.

@ast

Development of spontaneous ane ...... a mouse model of dyslipidemia.

@en

Development of spontaneous ane ...... a mouse model of dyslipidemia.

@nl

P1433

Q34235221-29F73997-6FA5-49E0-83E1-42B05C37EEDE

P1476

Q34235221-80020D76-0172-4BF8-BC62-6DC341A0C6DA

P2093

Q34235221-39A58E11-5AC4-4985-B573-E60A526F9DA3

Q34235221-41C59DA8-D1E8-4120-A948-0ED77A6C37A0

Q34235221-528F1E74-E48D-410E-82AA-E479944E0361

Q34235221-98927049-6FF3-4ECA-AB75-0138A714BF21

Q34235221-B54BE9BB-6824-46BE-9E44-5920F067ACFE

P2860

Q34235221-0A803E73-9BB4-4B54-B700-679A09D4FA81

Q34235221-0AB009DF-E1B0-426F-8E8F-8F2F3FF42062

Q34235221-1802BD60-F662-412B-8C59-4508D4BADD32

Q34235221-1F0F980A-3BCB-4E0C-8F49-26CA84A09DE6

Q34235221-2838D65C-CF01-4218-9A5C-20F459C92928

Q34235221-3368D8F6-8CAC-48F9-91A4-D80EBCD988D4

Q34235221-3CF029EE-55BA-42BF-964B-83984F6595FF

Q34235221-400A29ED-8146-416C-A0C2-E780386A4260

Q34235221-49227FA5-B9CF-454F-862E-71E17D526D78

Q34235221-49F8FBD5-3878-4605-A04C-10E9F957EA7F

P304

Q34235221-13131741-7564-408B-A371-71CFB1330973

P31

Q34235221-10209E09-44CD-4B63-9D85-C3D6531F943A

P356

Q34235221-5AF5B80A-D99D-47C8-A55B-61B495A64521

P407

Q34235221-F1A11A85-B5EB-4E78-BD2A-10E43E9FE81B

P433

Q34235221-A0380168-0E21-4C01-9664-804747EB346B

P478

Q34235221-3634D3F7-082D-4A7E-B3AA-B902F89C13AC

P50

Q34235221-36327EA6-9EC5-4403-BE03-321190DE0B7B

Q34235221-5A296AB7-F141-4AA1-BF75-5FA17C075507

Q34235221-B00EEF61-579A-4A07-AB36-9486D1D9A127

P577

Q34235221-4B7FDD6C-103D-428A-98F1-2AFA72BB2D03

P698

Q34235221-568965E8-CA00-421B-90F9-D37DBBC65F30

P921

Q34235221-620AB306-02FB-4927-8339-B348B6070254

P932

Q34235221-791A4BAB-7AE5-4A50-9142-FCEAA6516B60

P356

ATVBAHA.110.206045

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Development of spontaneous ane ...... a mouse model of dyslipidemia.

@en

P2093

Amy S Major

http://www.w3.org/2001/XMLSchema#string

Nicole A Braun

http://www.w3.org/2001/XMLSchema#string

Paul B Savage

http://www.w3.org/2001/XMLSchema#string

Roman Covarrubias

http://www.w3.org/2001/XMLSchema#string

Yanice V Mendez-Fernandez

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein-mediated pathways of lipid antigen presentation

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells

Glycolipid antigen induces long-term natural killer T cell anergy in mice.

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.

PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.

Immunotherapy with ligands of natural killer T cells.

The unconventional lifestyle of NKT cells.

Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis.

P304

1758-1765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.110.206045

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Steven A Porcelli

P577

2010-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20539017

http://www.w3.org/2001/XMLSchema#string

P921

P932

2963029

http://www.w3.org/2001/XMLSchema#string